The Journal of Experimental Medicine · 1983 · 53 citations · 54 references
Life SciencesHematologyImmunologyCancer ImmunologyInnate ImmunityMonoclonal AntibodiesCell-mediated ImmunityCytotoxic T Lymphocyte ResponsesNatural Killer Cell BiologyNatural Killer Cell FunctionCell ActivationIgg-mediated CytotoxicityImmune-mediated Cell LysisMixed Lymphocyte ReactionNatural Killer Cell CytotoxicityNatural Killer Cell Immunophenotypes
Cytotoxic cells are produced in an autologous mixed leukocyte reaction (AMLR). At 1 wk in culture the AMLR killers are mainly IgG Fc- cells and can kill autologous lymphoblastoid cell lines and Raji and Daudi targets that are usually resistant to natural killer cell (NK) lysis. To define the phenotype of these cells, we have used complement (C')-mediated lysis with monoclonal antibodies (MAb). AMLR killer activity was virtually eliminated by treatment with C' and 9.6 or 4F2, but the cytotoxic cells did not express NK-specific antigens, OKM1 and Leu-7, nor cytolytic T lymphocyte-specific antigens, 9.3 and OKT8. None of the 10 MAb used could significantly block cytotoxicity at the final concentration of 1.5 mcg/ml which is generally sufficient to inhibit CTL. The majority of cells at 1 wk in AMLR cultures stained with T cell activation antigens Ia and 4F2; AMLR killing was proportional to the percentage of 4F2+ cells but unrelated to the expression of Ia antigen.
54
Elizabeth A. Grimm, A Mazumder, H Z Zhang et al. · The Journal of Experimental Medicine · 1982 · 2.2K citations · Full text
Life Sciences, Immunology, Oncology +15
Ellis L. Reinherz, Patrick C. Kung, Gideon Goldstein et al. · Proceedings of the National Academy of Sciences · 1980 · 1.6K citations · Full text
Life Sciences, Immunology, Oncology +17
A monoclonal antibody reactive with human peripheral blood monocytes.
J Bréard, Ellis L. Reinherz, Patrick C. Kung et al. · The Journal of Immunology · 1980 · 833 citations · Full text